Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Jul 06 2021

· Issued by Morepen Laboratories Limited

Filed with NSE · · 4 pages · English

Summary by 6ix AI

Morepen Laboratories Limited has issued a press release regarding the production of a test batch of the Sputnik V vaccine in India, in collaboration with the Russian Direct Investment Fund. The announcement highlights the establishment of an exclusive production facility in Himachal Pradesh and the shipment of the first batch for quality control. This partnership is seen as a significant step towards expanding vaccine production capabilities in India and enhancing the availability of Sputnik V globally. The press release emphasizes the efficacy and safety of the Sputnik V vaccine, which has been registered in numerous countries worldwide.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Morepen Laboratories Limited has informed the Exchange regarding a press release dated July 06, 2021, titled "RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India".

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases